AGED Diagnostics

AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for early liver disease detection.

Based based in Silicon Valley, California, AGED Diagnostics works in medtech.

Profile

AGED Diagnostics is a pioneering lifetech and medtech company focused on developing accurate, non-invasive blood tests for early detection of liver disease. With a mission to disrupt the progression of fatty liver disease, AGED is addressing the critical need for effective non-invasive diagnostic tools in the healthcare industry. By utilizing targeted sequencing assessments, AGED is developing the first-of-its-kind blood test to diagnose MASH and stage liver fibrosis with exceptional accuracy. Through successful pilot studies and validation of core technology, AGED has identified biomarkers that can differentiate between benign and advanced forms of MASH with 90-99% accuracy. The company's innovative approach aims to replace current standards and improve upon existing imaging tools, ultimately enhancing patient outcomes by enabling early and accurate detection of liver disease.

Within the medtech space, the company focuses on its core offering rather than a broad product line.

Its base of operations is Silicon Valley, California.

Directory data places it at the Plug and Play portfolio startup stage.

Website: www.ageddiagnostics.com